About this trial
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo.
The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 21 to 50
English-speaking
cannabis smoking in past two months
heavy drinking in past two months
Disqualifiers
positive pregnancy test
nursing
positive urine toxicology screen for drugs other than cannabis
interest to quit or receive treatment for cannabis or alcohol use
Trial design
Factorial
Treatments tested in this trial
THC-dominant cannabis
DrugSmoked cannabis with 9.53% THC and 0.09% CBD
CBD-dominant cannabis
DrugSmoked cannabis with 0.35% THC and 11.27% CBD
Cannabis placebo
DrugSmoked placebo cannabis plant material
Alcohol
DrugDrink containing 0.3 g/kg of alcohol
Alcohol placebo
DrugPlacebo beverage contains only juice and a negligible trace of alcohol for masking
Treatment groups
Trial outcomes
Primary outcomes
ml of alcohol consumed
ml of alcohol consumed during the alcohol choice task
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Brown University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator